FDA-approved
Immune & defense
Polymyxin B / Colistin
Evidence
FDA approved
Class
Polypeptide antibiotics (polymyxins)
KEY TAKEAWAY
Polymyxin B and colistin (polymyxin E) are related cyclic lipopeptide antibiotics made by Paenibacillus bacteria. They are often kept as a last resort against resistant bacteria. Both are FDA-approved antibiotics for serious gram-negative infections. They are older drugs used mostly when other options fail.
Written by the Veylo editorial team · Updated
November 2026
What it is
Polypeptide antibiotics (polymyxins)
Approved for
Serious infections caused by resistant gram-negative bacteria
Key fact
Both are FDA-approved antibiotics for serious gram-negative infections. They are older drugs used mostly when other options fail.
Route
Intravenous, inhaled or topical depending on the product
Evidence strength
FDA approved
Polymyxin B and colistin (polymyxin E) are related cyclic lipopeptide antibiotics made by Paenibacillus bacteria. They are often kept as a last resort against resistant bacteria.
They bind the outer membrane of gram-negative bacteria and make it leaky, which kills the cell.
Both are FDA-approved antibiotics for serious gram-negative infections. They are older drugs used mostly when other options fail.
Serious infections caused by resistant gram-negative bacteria.
Kidney damage and nerve toxicity are the main concerns, so dosing and monitoring are careful.
U.S. FDA prescribing information for Polymyxin B / Colistin. DailyMed, National Library of Medicine.
Veylo content is educational and not medical advice. Peptides that are not FDA-approved are not approved for the uses described.